Status:
UNKNOWN
Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head
Lead Sponsor:
Pei-Yuan Lee, MD
Collaborating Sponsors:
Aeon Biotechnology Corporation
Conditions:
Avascular Necrosis of Femur
Bone Marrow
Eligibility:
All Genders
30-60 years
Brief Summary
This study aims to evaluate the effect of bone marrow concentration on avascular necrosis of femur head by comparing clinical and imaging outcomes between patients receiving core decompression surgery...
Detailed Description
Avascular necrosis (AVN) of femoral head is a progressive disease that predominantly affects younger patients. Although the exact pathophysiology of AVN has not yet to be elucidated, the disease is ch...
Eligibility Criteria
Inclusion
- Age between 30 and 60 years
- With diagnosis of avascular necrosis of femoral head, Stage I - Stage III
Exclusion
- With diagnosis of avascular necrosis of femoral head, Stage VI - Stage VI
- With prior history of hip surgery
- With current or prior history of trauma or infection at hip
- Platelet count \< 50,000/µL
- With current diagnosis of coagulopathy
- With current or prior history of cancer
- With current or prior history of hematological disease
- Pregnancy
- Patients who will not cooperate with one-year followup
Key Trial Info
Start Date :
April 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03787329
Start Date
April 14 2017
End Date
December 1 2020
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Show Chwan Memorial Hospital
Changhua, Changhua, Taiwan, 500